MatthewJWalterMD

Hematologic Oncology

Professor, Internal Medicine, Washington University School of Medicine

Dr. Walter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110
Phone+1 314-454-8304

Fax+1 314-454-5902

Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1998 - 2002
Johns Hopkins UniversityResidency, Internal Medicine, 1995 - 1998
Saint Louis University School of MedicineClass of 1995

PubMed

Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response.
Meagan A Jacoby, Eric D Duncavage, Ajay Khanna, Gue Su Chang, Sridhar Nonavinkere Srivatsan
Leukemia. 2024-10-04
The DNA Methyltransferase Inhibitor 5-Aza-4'-thio-2'-Deoxycytidine Induces C>G Transversions and Acute Lymphoid Leukemia Development.
Ryan M Bertoli, Yang Jo Chung, Michael J Difilippantonio, Anthony Wokasch, Madison R B Marasco
Cancer Research. 2024-08-01
Plasma Proteomic Signature Predicts Myeloid Neoplasm Risk.
Duc Tran, J Scott Beeler, Jie Liu, Brian Wiley, Irenaeus C C Chan
Clinical Cancer Research. 2024-08-01

Journal Articles

Discriminating a Common Somatic ASXL1 Mutation (c.1934dup; p.G646Wfs*12) from Artifact in Myeloid Malignancies Using NGS
Jonathan W Heusel, Richard D Press, Matthew J Walter, Eric J Duncavage, Nature

Abstracts/Posters

Mutant U2AF1S34F and U2AF1Q157P Induce Distinct RNA Splicing and Hematopoietic Phenotypes In Vivo
Matthew J. Walter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Clonal Cytopenias of Undetermined Significance Are Common in Cytopenic Adults Evaluated for MDS in the National MDS Study
Matthew J. Walter, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Understanding and Targeting TP53 in Myeloid Malignancies
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Translating Pathophysiological Advances Into Innovative Treatments for Myelodysplastic Syndromes and Related Myeloid Neoplasms
60th American Society of Hematology Annual Meeting - 11/30/2018

Damon Runyon Cancer Research Foundation Awards $4.8 Million to Rising InvestigatorsJuly 15th, 2021
$5 Million Grant Endows Research to Advance Blood Disorder TherapiesSeptember 11th, 2019
Washington University Medicine St. Louis: An Elite Investigative Hub for Acute Myeloid LeukemiaSeptember 3rd, 2019
Join now to see all

Genetics Of Myelodysplastic SyndromesNational Heart, Lung, And Blood Institute2011–2012
Genetic Progression Events In Murine APLNational Heart, Lung, And Blood Institute2005–2009